-
-
-
-
-
-
-
Abeona Therapeutics (ABEO) Tops Q3 EPS by 17c
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Abeona Therapeutics (ABEO)
-
-
-
-
-
-
-
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
-
-
-
-
-
-
-
Abeona Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Abeona Therapeutics Reports First Quarter 2022 Financial Results
-
-
-
-
-
-
-
Abeona Therapeutics Reports Second Quarter Financial Results
-
-
-
-
-
-
-
Pre-Open Stock Movers 08/17: (CVAC) (TCON) (GOLD) Higher; (SRNE) Lower (more...)
-
1,197,288 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

